Anemia in Pregnancy as a Predisposing Factor of Severe Preeclampsia: Anemia dalam Kehamilan sebagai Salah Satu Faktor Predisposisi Preeklamsia Berat by Nugraha, Gagah B.A. et al.
Anemia in Pregnancy as a Predisposing Factor of Severe Preeclampsia
Anemia dalam Kehamilan sebagai Salah Satu Faktor Predisposisi Preeklamsia Berat
Gagah B. A. Nugraha1, Prakosa J. Prasetyo2, Daliman3
1Ajibarang General Hospital, Banyumas
2Harapan Anda General Islamic Hospital, Tegal
3Division of Fetomaternal 
Laboratory Obstetrics and Gynecology Universitas Jendral Sudirman
Margono Soekarjo General Hospital, Purwokerto
Correspondence author. Gagah B.A. Nugraha. Ajibarang general hospital, Banyumas. gagahnugroho_dr@yahoo.com
Case Report
Vol 9. No 2. April 2021 Anemia in Pregnancy 111
Abstract
Objective: This case may partly explain that anaemia can be 
a predisposing factor for the development of many women 
with preeclampsia were have a low level of haemoglobin 
during their pregnancy.
Methods: A case report
Case: We present a case 23-year-old pregnant woman who 
has had moderate anemia with severe preeclampsia at 38-
week pregnant. As the evidence, there were elevated blood 
pressure, decreasing haemoglobin obtained by routine 
blood analysis, and presence of urine protein by urinalysis 
examination. 
Conclusions: In terms of anemia as one of a predisposing 
factor of preeclampsia it is important to care provider, 
pregnant women, and families to prevent anemia in 
pregnancy through routine ANC.
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Abstrak
Tujuan: Kasus ini sebagian dapat menjelaskan bahwa anemia 
dapat menjadi faktor predisposisi bagi perkembangan 
banyak perempuan dengan preeklamsia yang memiliki 
kadar hemoglobin yang rendah selama masa kehamilan 
mereka.
Metode: Laporan kasus. 
Kasus: Kami melaporan kasus ibu hamil berusia 23 tahun 
yang mengalami anemia sedang dengan preeklamsia berat 
di usia 38 minggu, dibuktikan dari peningkatan tekanan 
darah, penurunan hemoglobin, serta protein uria pada 
pemeriksaan urinalisis.
Kesimpulan: Berkaitan antara anemia sebagai predisposisi 
preekalmsia, penting bagi petugas kesehatan dan ibu hamil 
serta keluarga untuk mencegah anemia dalam kehamilan 
melalui ANC yang rutin.
Kata kunci: anemia, kehamilan, preeklamsia berat.
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INTRODUCTION
Anemia in pregnancy is a common problem 
that can occur in developed and developing 
countries. In 2015 the World Health Organization 
(WHO) published that 83.2% of pregnant women 
globally are anemic, while in Indonesia alone is 
estimated anemia can occur in 30% of pregnant 
women.1
The defi ciency of micronutrients such as folic 
acid and iron is the most common aetiology of 
anaemia in pregnant women. Increased nutrients 
transfer from maternal to fetal causes maternal 
depleted in micronutrient reserves which serve 
as primary substances for erythropoiesis.2 Based 
on scientifi c studies, anemia is associated with 
maternal mortality and morbidity due to broadly 
20% of maternal deaths caused by anemia,3 
except that in the process of pregnancy, anemia 
can lead to other problems indicated one of 
them is preeclampsia. Preeclampsia is one of the 
problems of maternal and perinatal, especially 
in developing countries. Although it has the 
distinction of variation between countries, the 
incidence rates of preeclampsia are estimated 
to reach 1.8% - 16.7% of all pregnant women 
in The world.4,5 Indonesian Demographic Health 
Survey in 2013, approved that preeclampsia is 
at the second position (27.1%) of the fi ve causes 
of maternal deaths in Indonesia aside from 
haemorrhage, infection, and other abortions.6
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In matters relating to preeclampsia, there 
is still much research done to further assess 
the relationship between both of them. The 
effect of anaemia on preeclampsia is still being 
debated by experts to be approved.4 Therefore, 
on this occasion the researchers present the case 
of suspected anaemia predisposes to severe 
preeclampsia.
METHODS
Descriptive research of case reports. Primary data 
obtained by history and physical examination. 
Secondary data were obtained based on the 
results of laboratory and medical records. The 
study was conducted in the month of October 
2017.
CASE
A 23-year-old woman who was 38+2 weeks 
pregnant (Gravid 1, Para 0)  came to the 
emergency department at City Hospital. The 
patient had her routine antenatal care (ANC) at a 
community health clinic in her district as her fi rst 
tier health facility. In her 38 weeks of pregnancy, 
the patient discovered that she had high blood 
pressure as per told by the midwife. She had 
never high blood pressure during prior ANC. The 
patient denied complaints of headache, blurred 
vision, heartburn, and convulsions. Patients 
also have no history of hypertension or heart 
disease. At her routine ANC, Iron and folic acid 
supplements were given by the midwife which 
the patient had never consumed. There were no 
prior kidney injury on this patient.
On a physical examination, the patient 
presented with blood pressure of 160/110 mmHg, 
pulse rate of 84 beat per minute respiration rate 
at 22 breaths per minute, and temperature at 
36,7 oC. The patient fundal height is at 34 cm with 
fetal back in the left maternal side, fetal heartbeat 
is at 140 beat per minute, and there was no 
contraction occurred. Laboratory fi ndings were 
normal except haemoglobin which at the level 
of 7,3 g/dl and a qualitative test of proteinuria 
which showed at +4. Morphological examination 
of red blood cells showed normocytic and 
normochromic erythrocyte. The patient was 
diagnosed as anemic with severe preeclampsia 
at a 38-week pregnancy. Further management 
included has observation of vital signs and 
labour progress, stabilization with parenteral 
fl uid and MgSO4 administration 4 gr loading 
dose and 5 gr intramuscular of maintenance at 
each right and left gluteus, urinary catheter, oral 
nifedipine 10 mg every 8 hours, cardiotocography 
examination for monitor fetal wellbeing and 
induction of labour with misoprostol 1/8 tablet 
every 4 hours. Stage two labour decided to be 
assisted with extraction vacuum management. 
Communications, information and education 
were provided to the patients and families about 
the potential complications. The prognosis of this 
patient was dubia.
DISCUSSION
The patients were diagnosed through steps 
anamnesis, physical examination and laboratories 
investigations. The patient was a women with 
obstetric status Gravid 1, Para 0 expected full-
term pregnancy, according to calculations First 
Day of Last Menstrual (DLM). Williams 24th 
edition states of gestation between 371/7 to 416/7 
weeks is included in the full-term pregnancy, 
Further anamnesis obtained information that 
the patient's routine did the ANC, but didn’t 
consume folic acid and iron tablets from the 
midwife. As additional information in the end of 
full-term pregnancy, the patient had increased 
blood pressure.7 
On Physical examination, the patient had 
160/110 mmHg blood pressure with a pulse, 
respiratory rate and temperature within normal 
limits. Based on recent guidelines, diagnosis of 
severe preeclampsia can be made by at least one 
of six criteria which are systolic blood pressure 
≥ 160 mmHg, hepatic failure, progressive renal 
insuffi ciency, cerebral dysfunction, pulmonary 
oedema, and trombocytopenia.8 In this case, the 
patient blood pressure was at 160/110 mmHg 
with other parameters of vital sign within normal 
limits. Qualitative test of proteinuria resulted at 
+4 level of proteinuria. Two criteria were already 
fulfi lled by the patient. Thus, the patient was 
diagnosed as severe preeclampsia. To be precise 
this case is a late-onset preeclampsia because it 
occurs at gestational age at more than 34 weeks.9 
This is proven by the documentation in the 
patients ANC record. The patient blood pressure 
was normal until the gestational age of 38 weeks.
The diagnosis of anemia is made by a 
laboratory fi nding of haemoglobin at the 
level of 7.3 g/dl. The patient also admitted 
that she did not consume any of the antenatal 
supplements such as folic acid and iron. Within 
this haemoglobin level patient was pronounced 
to have moderate anemia ( Hb 7-9.9 g / dl ) 
which is belong to anemia with normochromic 
normocytic erythrocyte morphology.2
Preeclampsia can induced anemia by 
mechanism of the red blood cells become 
fragmented as it passes through the blood vessels 
with damaged endothelium cells and fi brin, it 
causes hemolytic anemia. Damage to the blood 
vessels will lead to the use of platelets so that the 
number of platelets in the blood decreases. If the 
mechanism continues, are likely to be an increase 
in lactate dehydrogenase (LDH), followed by 
apoptosis and necrosis of hepatocytes cells, 
characterized by elevated liver enzymes (HELLP 
Syndrome).10 In this case we found that LDH 
in the normal range for pregnancy with there 
were no either elevated liver enzyme or renal 
insuffi ciency, so that hemolytic anemia caused by 
preeclampsia can be ignored.
During pregnancy, there is a disproportionated 
increase in plasma volume, red blood cell volume, 
type. A study conducted by Karaoglu et al 
(2010) stated that anemia due to micronutrient 
defi ciency of folic acid can cause macrocytic 
anemia and iron defi ciency causes microcytic 
anemia. But when folic acid defi ciency occurs 
simultaneously with iron defi ciency this 
results in normocytic erythrocyte. This type  of 
micronutrient defi ciency anemia basically causes 
the number of MCV exceeds normal level which 
explained why the morphologycal examination 
showed normal size of the erythrocyte.3,15 
and haemoglobin mass. The plasma volume is 
higher than the level of red blood cells which 
leads to hemodilution.11 This makes adequate 
iron intake is required during pregnancy from 
both additional supplements or food daily.12 
Micronutrient defi ciency anaemia results in an 
increase in serum norepinephrine concentration, 
thus inducing the synthesis of corticotropin-
releasing hormone (CRH) produced by the 
placenta, this condition enhances CRH stimulation 
resulting in increased infl ammatory cytokines, 
glucocorticoids, oxidative stress.9 Increased 
oxidative stress stimulates angiotensin receptor 
1-autoantibodies (AT1-AAs). The formation of 
AT1-AA will induce sFlt-1 and sEng that bind to 
the vascular endothelial growth factor (VEGF) and 
placental growth factor (PlGF).13 This condition 
leads to systemic vascular dysfunction resulting 
in an increase in blood pressure characterized 
by decreased Nitric Oxide (NO) and elevated 
endothelin. Hence, the fi nding of proteinuria.14
CONCLUSION
Anemia in pregnancy often occurs because of a 
defi ciency of folic acid and iron micronutrients. 
Thus defi ciency can lead synthesis of CRH as a 
basic mechanism of elevated blood pressure. A 
routine ANC visit could be a scheme to prevent 
the occurrence of micronutrient defi ciency. 
In terms of its association with preeclampsia, 
anemia is thought to have a role as the cause 
of the emergence of preeclampsia, therefore it 
is important to care provider, pregnant women, 
and families to prevent anaemia in pregnancy.
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Figure 1. Summary of the pathogenesis of preeclampsia11
Micronutrient defi ciency anaemia is included in the normocytic erythrocyte anaemia
1. WHO. The Global Prevalence of Anaemia in 2011. 
Geneva : Elysium-WHO Document Production Service. 
2015.
2. Achebe MM, Gafter-Gvili A. How I Treat Anemia In 
Pregnancy: Iron, Cobalamin, and Folate. Blood. 2017; 
129(8): 940-9. doi.org/10.1182/blood-2016-08-672246.
3. Karaoglu L, Pehlivan E, Egri M, Deprem C, Gunes G, 
Genc MF, Temel I. The Prevalence of Nutritional Anemia 
In Pregnancy In An East Anatolian Province, Turkey. 
BMC Public Health. 2010; 10: 329-41. doi:10.1186/1471-
2458-10-329.
4. Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk 
Factors of Pre-Eclampsia/Eclampsia and Its Adverse 
Outcomes In Low and Middle-Income Countries: A 
WHO Secondary Analysis. PLoS One. 2014;9(3): 1-8. doi.
org/10.1371/journal.pone.0091198. 
5. Osungbade KO, Ige OK. Public Health Perspectives of 
Preeclampsia In Developing Countries: Implication For 
Health System Strengthening. J Preg. 2011;481095:1-6 
doi:10.1155/2011/481095
6. Kementerian Kesehatan Republik Indonesia. Infodatin 
Situasi Kesehatan Ibu. Kemenkes RI, Pusat data dan 
informasi. 2014. 
7. Cunningham F.G, Leveno K.J, Bloom F.L, Spong C.Y, 
Dashe J.S, Hoffman B.L, Casey B.M Sheffi eld JS. Williams 
Obstetrics 24e. New York : McGraw Hill. 2014.
8. Berghella V. Maternal-Fetal Evidence-Based Guidelines. 
3rd ed. New York: CRC Press. 2017. 
9. Devi N, Varalaxmi B, Jyothirmayi T, Lahari N. Maternal 
Outcome In Pregnancy With Severe Anaemia: 
Prospective Study In A Tertiarycare Hospital In Andhra 
Pradesh. J Dental Med Sci. 2015; 14(4): 6-10.
10. Abildgaard U, Heimdal K. Pathogenesis of The 
Syndrome of Hemolysis, Elevated Liver Enzymes, and 
Low Platelet Count (HELLP): A Review. Eur J Obstet 
Gynecol Reprod Biol. 2013; 166(2): 117-23. doi:10.1016/j.
ejogrb.2012.09.026.
11. Sharma JB, Shankar M. Anemia in Pregnancy. J Int Med 
Scien Academy. 2010; 23(4): 253-60.
12. Peraturan Menteri Kesehatan Nomor 88 tahun 2014 
tentang Standar Tablet Tambah Darah Bagi Perempuan 
Usia Subur dan Ibu Hamil.2014 .s
13. Zhou CC, Irani RA, Zhang Y, Blackwell SC, Mi T, Wen 
J, et al. Angiotensin Receptor Agonistic Autoantibody-
Mediated Tumor Necrosis Factor-Α Induction 
Contributes to Increased Soluble Endoglin Production 
In Preeclampsia. Circul. 2010; 121(3): 436-44.
14. Lovgren TR, Dugoff L, Galan HL. Uterine Artery Doppler 
and Prediction of Preeclampsia. Clin Obstet Gynecol. 
2010; 53(4): 888-98.
15. Johnson Wimbley TD, Graham DY. Diagnosis and 
Management of Iron Defi ciency Anemia In The 21st 
Century. Therapeutic Advances  Gastroenterol. 2011; 
4(3) : 177-84. 
REFERENCES
114 Nugraha, Prasetyo and Daliman
Indones J
Obstet Gynecol
